Page last updated: 2024-08-24

topotecan and arc 31

topotecan has been researched along with arc 31 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LaVoie, EJ; Li, TK; Liu, A; Liu, LF; Ray, A; Ruchelman, AL; Singh, SK; Wu, X; Yang, JM1
LaVoie, EJ; Li, TK; Liu, A; Liu, LF; Ruchelman, AL; Singh, SK1

Other Studies

2 other study(ies) available for topotecan and arc 31

ArticleYear
Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435.
    Bioorganic & medicinal chemistry letters, 2002, Nov-18, Volume: 12, Issue:22

    Topics: Animals; Antineoplastic Agents; Aza Compounds; Cell Division; Chrysenes; DNA; Enzyme Inhibitors; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Topoisomerase I Inhibitors; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured

2002
Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity.
    Journal of medicinal chemistry, 2003, May-22, Volume: 46, Issue:11

    Topics: Amines; Antineoplastic Agents; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Naphthyridines; Nitro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured

2003